证券代码：301234 证券简称：五洲医疗 公告编号：2025-024 安徽宏宇五洲医疗器械股份有限公司 第三届董事会第九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 安徽宏宇五洲医疗器械股份有限公司（以下简称"公司"）第三届董事会第 九次会议于 2025 年 8 月 20 日以现场结合通讯方式在公司会议室召开，会议于 2025 年 8 月 12 日以书面和通讯方式通知全体董事。本次会议应出席董事 7 名， 实际出席董事 7 名。 本次会议由公司董事长黄凡先生主持，公司监事及高级管理人员列席了会议。 会议的召开符合《公司法》等法律法规、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 1、审议通过《2025 年半年度报告》及报告摘要 公司《2025 年半年度报告》及报告摘要的编制程序符合相关法律法规、部 门规章和规范性文件等的规定，报告内容真实、准确、完整地反映了公司 2025 年半年度的财务状况、经营成果和现金流量，不存在任何虚假记载、误导性陈述 或者重大遗漏。 表决结果：同意 7 票，反对 0 票，弃权 ...

安徽宏宇五洲医疗器械股份有限公司 2025 年半年度报告 二〇二五年八月二十日 安徽宏宇五洲医疗器械股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人黄凡、主管会计工作负责人季宇及会计机构负责人(会计主管 人员)季宇声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告中如有涉及未来的计划、业绩预测等方面的内容，均不构成公司对 任何投资者及相关人士的实质承诺，投资者及相关人士均应对此保持足够的 风险认识，并且应当理解计划、预测与承诺之间的差异。敬请投资者注意投 资风险。 本公司敬请投资者认真阅读本报告全文，并特别注意公司在经营中可能面 临的行业周期性波动风险、市场竞争日益加剧风险、产品质量控制风险、持 续研发与创新风险、毛利率下滑风险、汇率波动风险、应收账款回款风险及 客户流失等风险因素，注意投资风险。具体内容详见本报告第三节"管理层 讨论与分析"之"十、公司面临的风险和 ...

Group 1 - The latest stock price of Wuzhou Medical is 41.29 yuan, an increase of 0.77 yuan from the previous trading day's closing price, representing a rise of 1.90% [1] - During the trading session, the stock reached a high of 42.50 yuan and a low of 40.06 yuan, with a trading volume of 35,711 hands and a transaction amount of 147 million yuan [1] - On August 19, Wuzhou Medical experienced a rapid rebound, with a rise of over 2% within 5 minutes and a transaction amount of 15.86 million yuan [1] Group 2 - The data indicates that on that day, the net inflow of main funds was 13.53 million yuan, and the cumulative net inflow of main funds over the past five days was 9.34 million yuan [1] - Wuzhou Medical operates in the medical device sector, focusing on product research and development as well as production in the healthcare field [1] - The company's business includes medical consumables, equipment, and related technical services, with a market presence in both domestic and overseas regions [1]

Group 1 - The core viewpoint of the articles highlights the performance and market position of Wuzhou Medical, which closed at 41.29 yuan with a PE ratio of 78.60 times, significantly higher than the industry average of 59.49 times [1][2] - Wuzhou Medical's total market capitalization is 2.808 billion yuan, ranking 99th in the medical device industry based on PE ratio [1][2] - The company experienced a net inflow of main funds amounting to 13.53 million yuan on August 19, with a total inflow of 9.34 million yuan over the past five days [1] Group 2 - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, with key products including syringes, safety syringes, insulin syringes, and various other medical supplies [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 104 million yuan, representing a year-on-year increase of 15.59%, while net profit was 5.63 million yuan, reflecting a year-on-year decrease of 43.00% [1] - The sales gross margin for the company stands at 14.62% [1]

Core Viewpoint - The stock of Wuzhou Medical (301234) has shown a slight increase, with a closing price of 40.52 yuan on August 18, 2025, reflecting a 0.47% rise, while the company faces challenges in profitability and market position within the medical device industry [1][3]. Financial Performance - Wuzhou Medical reported a main business revenue of 104 million yuan for Q1 2025, representing a year-on-year increase of 15.59% [3]. - The net profit attributable to shareholders was 5.63 million yuan, down 43.0% year-on-year, and the non-recurring net profit was 4.56 million yuan, down 44.82% year-on-year [3]. - The company's debt ratio stands at 10.75%, with investment income of 1.96 million yuan and financial expenses of -1.15 million yuan [3]. Market Position and Valuation - Wuzhou Medical's total market capitalization is 2.755 billion yuan, significantly lower than the industry average of 12.121 billion yuan, ranking 112 out of 123 in the medical device sector [3]. - The company has a price-to-earnings (P/E) ratio of 122.25, compared to the industry average of 78.11, indicating a higher valuation relative to earnings [3]. - The gross margin is 14.62%, substantially below the industry average of 51.35%, ranking 120 out of 123 [3]. Capital Flow Analysis - On August 18, 2025, the net outflow of main funds was 3.97 million yuan, accounting for 2.98% of the total transaction amount, while retail funds saw a net outflow of 1.42 million yuan, representing 1.07% of the total [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net inflows from retail investors on certain days, indicating varying investor sentiment [2].

Core Viewpoint - Wuzhou Medical's stock closed at 40.33 yuan on August 15, experiencing a decline of 1.99%, with a rolling PE ratio of 76.78 times, and a total market capitalization of 2.742 billion yuan [1] Group 1: Company Performance - Wuzhou Medical's main business includes the research, manufacturing, and sales of disposable sterile infusion medical devices, as well as other diagnostic and nursing-related medical supplies [1] - The latest quarterly report for Q1 2025 shows the company achieved operating revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a sales gross margin of 14.62% [1] Group 2: Industry Comparison - The average PE ratio for the medical device industry is 56.58 times, with a median of 39.97 times, positioning Wuzhou Medical at 97th place in the industry ranking [1] - The PE ratios of other companies in the industry range from 11.36 times for Jiuan Medical to 20.86 times for Antu Biology, indicating a significant variance in valuation within the sector [2]

Core Viewpoint - Wuzhou Medical's stock closed at 43.85 yuan, up 3.03%, with a rolling PE ratio of 83.48, marking a new low in 481 days, and a total market value of 2.982 billion yuan [1] Group 1: Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices and other related medical supplies [1] - The main products include syringes, safety syringes, insulin syringes, infusion devices, blood transfusion devices, and various types of needles [1] Group 2: Financial Performance - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00% [1] - The gross profit margin for sales was 14.62% [1] Group 3: Shareholder Information - As of July 31, 2025, Wuzhou Medical had 7,255 shareholders, an increase of 848 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 4: Industry Comparison - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Wuzhou Medical at 101st in the industry ranking [1][2] - The industry average market value is 120.28 billion yuan, while Wuzhou Medical's market value is significantly lower at 2.982 billion yuan [2]

Core Viewpoint - Wuzhou Medical's stock closed at 42.56 yuan, marking a 1.19% increase, with a rolling PE ratio of 81.02, the lowest in 480 days, and a total market value of 2.894 billion yuan [1] Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, as well as integrated supply of other diagnostic and nursing medical supplies [1] - The main products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, injection needles, intravenous infusion needles, blood collection needles, insulin pen needles, safety needles, safety blood collection needles, blood pressure monitors, and masks [1] Financial Performance - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00%, with a gross profit margin of 14.62% [1] Shareholder Information - As of July 31, 2025, Wuzhou Medical had 7,255 shareholders, an increase of 848 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Wuzhou Medical at 101st in the industry ranking [1][2]

Company Overview - Wuzhou Medical's stock price closed at 42.06 yuan on August 8, 2025, down 0.78% from the previous trading day [1] - The opening price was 42.21 yuan, with a daily high of 43.24 yuan and a low of 41.61 yuan, resulting in a trading range of 3.85% [1] - The trading volume was 21,121 hands, with a transaction amount of 0.89 billion yuan and a turnover rate of 3.11% [1] Business Operations - Wuzhou Medical specializes in the research, development, production, and sales of medical devices, including medical consumables and equipment [1] - The company operates within the medical device industry and is also involved in related concepts such as medical aesthetics [1] Market Activity - On the morning of August 8, Wuzhou Medical experienced a rapid decline, with a drop of over 2% within 5 minutes [1] - By the end of the trading day, the net inflow of main funds was 2.773 million yuan, accounting for 0.1% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds was 1.8575 million yuan [1]

Group 1 - The stock price of Wuzhou Medical is reported at 40.80 yuan as of August 6, 2025, with a decrease of 1.30 yuan, representing a decline of 3.09% from the previous trading day [1] - The stock reached a low of 40.24 yuan and a high of 42.23 yuan during the trading session, with a volatility of 4.73% [1] - A quick rebound was observed at 10:48 AM, where the stock price increased by over 2% within 5 minutes, recovering to 41.58 yuan [1] Group 2 - Wuzhou Medical specializes in the research and production of medical devices, including products in the medical beauty consumables sector [1] - The company is registered in Anhui Province and holds the qualification of a specialized and innovative enterprise [1] - The current total market capitalization is 2.774 billion yuan, with the circulating market value equal to the total market value [1] Group 3 - On August 6, the net outflow of main funds was 97,700 yuan, with a cumulative net outflow of 16.2434 million yuan over the past five trading days [1] - The trading volume for the day was 45,039 hands, with a transaction amount of 185 million yuan, resulting in a turnover rate of 6.62% [1]